Herpes simplex virus (HSV) uses intranuclear compartmentalization to concentrate the viral and cellular factors required for the progression of the viral life cycle. Processes as varied as viral DNA replication, late gene expression, and capsid assembly take place within discrete structures within the nucleus called replication compartments. Replication compartments are hypothesized to mature from a few distinct structures, called prereplicative sites, that form adjacent to cellular nuclear matrix-associated ND10 sites. During productive infection, the HSV single-stranded DNA-binding protein ICP8 localizes to replication compartments. To further the understanding of replication compartment maturation, we have constructed and characterized a recombinant HSV-1 strain that expresses an ICP8 molecule with green fluorescent protein (GFP) fused to its C terminus. In transfected Vero cells that were infected with HSV, the ICP8 -GFP protein localized to prereplicative sites in the presence of the viral DNA synthesis inhibitor phosphonoacetic acid (PAA) or to replication compartments in the absence of PAA. A recombinant HSV-1 strain expressing the ICP8 -GFP virus replicated in Vero cells, but the yield was increased by 150-fold in an ICP8-complementing cell line. Using the ICP8 -GFP protein as a marker for replication compartments, we show here that these structures start as punctate structures early in infection and grow into large, globular structures that eventually fill the nucleus. Large replication compartments were formed by small structures that either moved through the nucleus to merge with adjacent compartments or remained relatively stationary within the nucleus and grew by accretion and fused with neighboring structures.
Introduction
Herpes simplex virus (HSV) is a large double-stranded DNA virus that replicates within the nucleus of the infected cell. As such, many viral processes must occur within the nucleus during the course of infection including viral transcription (Knipe et al., 1987; Leopardi et al., 1997; Phelan et al., 1997; Randall and Dinwoodie, 1986; Rice et al., 1994) , viral DNA synthesis (de Bruyn Kops and Phelan et al., 1997; Randall and Dinwoodie, 1986) , and virion assembly and DNA packaging (de Bruyn Kops et al., 1998; Lamberti and Weller, 1998; Ward et al., 1996; Yu and Weller, 1998) . While these processes are temporally regulated by the viral cascade of immediate-early, early, and late gene expression (Roizman and Knipe, 2001 ), there is an additional level of spatial control imposed within the nucleus. Viral processes do not take place diffusely within the nucleus, but within globular intranuclear structures called replication compartments (Bush et al., 1991; de Bruyn Kops and Knipe, 1988; de Bruyn Kops et al., 1998; Knipe et al., 1987; Phelan et al., 1997; Quinlan et al., 1984) .
HSV employs the strategy of intranuclear compartmentalization to organize the processes required for viral replication, which allows for the local accumulation of diffuse or limiting factors, be they individual proteins, large protein complexes, or small biological molecules, to promote a biological process. The mammalian cell uses compartmentalization to organize intranuclear operations, with subcompartments associated with various cellular processes. The majority of the nucleus is composed of the chromatin compartment, which is subdivided into transcriptionally active euchromatin or transcriptionally silent heterochromatin. Individual chromosomes occupy defined regions within the nucleus called "chromosome territories," with euchromatin more centrally located within the nucleus and the heterochromatin located near the nuclear periphery (Abney et al., 1997; Carmo-Fonseca, 2002; Chubb et al., 2002; Ferreira et al., 1997; Manders et al., 1999; Qumsiyeh, 1999; Sadoni et al., 1999; Zink et al., 1998) .
Running throughout the interchromosomal spaces are channels or streams of nucleoplasm in which processes involved in RNA metabolism and trafficking are found (Politz and Pederson, 2000) . Other nuclear compartments within the interchromosomal spaces include the nucleolus, which is the major site of ribosome biogenesis (CarmoFonseca et al., 2000) , the nuclear speckles that house spliceosomal components (Misteli et al., 1997) , the Cajal bodies (formerly known as coiled bodies) that are involved in the generation of snRNPs (Gall, 2000) , and the ND10 sites, which may serve as depots for transcriptional regulators (Ascoli and Maul, 1991; Everett et al., 1999; Hodges et al., 1998; Maul et al., 2000; Zhong et al., 2000) . Many of these structures, such as chromatin and the ND10 sites, are anchored within the nucleus by direct association with the nuclear matrix (Ascoli and Maul, 1991; Chubb et al., 2002; Hodges et al., 1998) , while others are associated with specific genomic loci, as is the case with Cajal bodies and histone gene clusters (Gall, 2000) . Within this well-organized intranuclear environment, the virus must initiate its life cycle by accumulating the required cellular and viral factors and the incoming parental genome at the same site within the host nucleus. The assembling of these sites is influenced and possibly limited by the preexisting nuclear architecture (de Bruyn Kops and Knipe, 1994) . For example, in binucleate CV-1 cells infected with HSV, similar patterns of replication compartments, some even mirror images, were observed in the adjacent sister nuclei (de Bruyn Kops and Knipe, 1994) .
Replication compartments were initially defined by the presence of the HSV single-stranded DNA-binding protein, ICP8 (Quinlan et al., 1984) . Other viral proteins known to accumulate within replication compartments include the origin-binding protein (U L 9), the heterotrimeric helicase-primase complex (U L 5/U L 8/U L 52), polymerase and its accessory factor (U L 30/U L 42), the immediate-early ICP27 protein, the ICP4 viral transactivator protein, and the ICP5 capsid protein (Bush et al., 1991; de Bruyn Kops et al., 1998; Knipe et al., 1987; Liptak et al., 1996; Lukonis and Weller, 1996; Phelan et al., 1997) . Cellular proteins that are involved in DNA replication, such as PCNA, DNA ligase, and RP-A, are also recruited to replication compartments (de Bruyn Kops and Knipe, 1988; Wilcock and Lane, 1991) , but their participation in viral replication has not been determined. The above-mentioned viral proteins are contained within subcompartments within replication compartments, with some proteins, such as ICP8, distributed to punctate foci within compartments, and others, such as ICP4, distributed diffusely within compartments (de Bruyn Kops et al., 1998). Viral DNA synthesis, as detected by BrdU incorporation (de Bruyn Kops and , and viral transcription, as detected by RNA pulse-labeling and by the presence of the cellular RNA polymerase II (Leopardi et al., 1997; Phelan et al., 1997; Rice et al., 1994) , both occur within replication compartments.
In the absence of viral replication, as with the treatment with the viral DNA synthesis inhibitor phosphonoacetic acid (PAA), the viral replication proteins including ICP8, the origin-binding protein, and the helicase-primase complex are distributed within the nucleus to punctate structures called prereplicative sites (de Bruyn Kops and Knipe, 1988; Liptak et al., 1996; Lukonis and Weller, 1996; Quinlan et al., 1984) . Because the replication proteins associate with these structures in the absence of viral DNA synthesis, they are hypothesized to be an early stage of protein accumulation and, thus, the precursors to replication compartments. However, in the presence of PAA, two populations of prereplicative sites are observed (Lukonis et al., 1997; Uprichard and Knipe, 1997) . One population, the S-phase-dependent prereplicative sites, co-localize with sites of cellular DNA synthesis, as shown by BrdU incorporation (Uprichard and Knipe, 1997) . In contrast, the other population, the S-phase-independent prereplicative sites, form adjacent to cellular ND10 sites (Uprichard and Knipe, 1997) . The function of ND10 sites is unknown, but it has been suggested that they are involved in processes as varied as transcriptional control, cell growth and regulation, and antiviral defense (Ascoli and Maul, 1991; Maul et al., 2000; Negorev and Maul, 2001; Zhong et al., 2000) . The "nuclear domain 10" or ND10 structures vary in number in mammalian cells in the range of 10 -30 per nucleus, and are generally 0.2-1.0 m in diameter (Everett et al., 1999; Hodges et al., 1998; Zhong et al., 2000) . The size and number of ND10 structures change during the cell cycle, which varies with the presence of hormones or interferon, possibly via a pathway regulated by the promyelocytic leukemia protein (PML) (Everett et al., 1999; Hodges et al., 1998; Negorev and Maul, 2001; Zhong et al., 2000) . While ND10 structures have been found in numerous cell types in cultured cells or in vivo, they have yet to be detected in cells of a neuronal lineage (Negorev and Maul, 2001) . The role that ND10 structures play in viral infection is also unclear as these structures are disrupted soon after infection by the viral immediate-early gene product ICP0, possibly via a proteasome-dependent mechanism (Everett et al., 1998; Everett and Maul, 1994) . It has previously been shown that incoming genomes of various viruses including HSV, SV40, and adenovirus are deposited near ND10 structures in the absence of viral protein production via an unknown mechanism Maul et al., 1996) . However, the cellular machinery that one might imagine that a virus would require to replicate its genome is not present at these sites and must be recruited to the parental genome(s). In contrast, the S-phase-dependent sites are regions of active cellular DNA synthesis and presumably contain the cellular machinery needed for viral DNA synthesis (de Bruyn Kops and Uprichard and Knipe, 1997) . It is possible that the virus may usurp these preformed replication complexes for its own purposes and that these sites are the precursors of viral replication compartments.
ICP8 is a 125-kDa multifunctional zinc metalloprotein encoded by the U L 29 gene (Gao et al., 1988; Gupte et al., 1991; Quinn and McGeoch, 1985) and is expressed with early kinetics (Honess and Roizman, 1974) . ICP8 exhibits a preference for binding single-stranded DNA, but can bind double-stranded DNA (Lee and Knipe, 1985; Ruyechan, 1983; Ruyechan and Weir, 1984) . ICP8 binds nonspecifically to DNA in a cooperative manner (Lee and Knipe, 1985) . ICP8 also has the ability to destabilize doublestranded DNA (Boehmer and Lehman, 1993a) and can promote DNA strand transfer (Bortner et al., 1993) and renaturation of complementary DNA strands (Dutch and Lehman, 1993) , which suggests that ICP8 may play a role in HSV genome recombination. In addition to its role in viral DNA synthesis, ICP8 has also been shown to regulate viral gene expression by repressing transcription from the parental genome (Godowski and Knipe, 1983; Godowski and Knipe, 1985; Godowski and Knipe, 1986) and stimulating late gene expression from progeny genomes (Chen and Knipe, 1996; Gao and Knipe, 1991) .
The requirements for the targeting of ICP8 within the nucleus may depend on the conditions examined. In transfected cells, the co-expression of the three components of the helicase-primase complex (U L 5, U L 8, and U L 52) is sufficient to localize ICP8 to punctate prereplicative sites (Liptak et al., 1996; Lukonis and Weller, 1996) . In infected cells, the requirements for ICP8 intranuclear localization may be different because, in addition to the helicase-primase complex, the origin-binding protein (U L 9) is also required (Liptak et al., 1996; Lukonis and Weller, 1996) . ICP8 has been shown to interact either physically or functionally with several of the other viral replication proteins including the origin-binding protein (Boehmer, 1998; Boehmer and Lehman, 1993b; He, 2001; Lee and Lehman, 1997; Makhov et al., 1996) , the helicase-primase complex (Falkenberg, Elias, and Lehman, 1998; Hamatake et al., 1997; Le Gac, 1996) , and polymerase (Chiou et al., 1985; Hernandez and Lehman, 1990; O'Donnell et al., 1987; Ruyechan and Weir, 1984) . As ICP8 is required for prereplicative site and replication compartment formation (de Bruyn Kops and Knipe, 1988; Liptak, Uprichard, and Knipe, 1996; Quinlan, Chen, and Knipe, 1984) , and because its intranuclear distribution is well characterized, we chose ICP8 as a marker for viral replication structures and to focus on the intranuclear movement of ICP8 as a model system to study replication compartment formation in infected cells. To achieve this, we fused the coding sequence from green fluorescent protein (GFP) to the C-terminal ICP8 sequence to analyze the formation of prereplicative sites and replication compartments in living cells.
Results
The number of viral functions occurring within replication compartments speaks to the significance of these structures in the viral replication cycle, but little is known about how these structures form and mature to occupy almost the entire volume of the nucleus (Monier et al., 2000) . We initiated these studies to determine if replication compartments originated from a few distinct structures in the nucleus or if they formed from the coalescence of numerous sites within the nucleus. It is likely that the few S-phaseindependent prereplicative sites observed adjacent to cellular ND10 sites (Uprichard and Knipe, 1997) and not the numerous S-phase-dependent prereplicative sites are the precursors to the large replication compartments observed later during infection (de Bruyn Kops and Knipe, 1988) , based on the evidence that the incoming viral genome and viral proteins accumulate at sites adjacent to ND10 sites Maul et al., 1996; Uprichard and Knipe, 1997) . However, it was unclear how these few small sites eventually form the large replication compartments observed later in infection. To analyze this, we constructed a recombinant HSV-1 strain expressing an ICP8 -GFP fusion protein to examine prereplicative site and replication compartment formation in cultured cells.
Construction of an ICP8 -GFP fusion gene
We first constructed vectors that expressed an ICP8 molecule with GFP fused to the C-or N-terminus. The Cterminal ICP8 -GFP fusion protein consists of the entire 1196 amino acid residues of ICP8, an 18-amino-acid residue linker region, and the 239 amino acid residues of GFP. The predicted size of the C-terminal ICP8 -GFP fusion protein was 157 kDa. The N-terminal GFP-ICP8 protein consisted of the 239 residues of GFP fused to the 1196 residues of ICP8 with 3 residues as a linker region. We constructed plasmids that expressed a C-terminal ICP8 -GFP fusion protein under the control of the CMV promoter pCMV-8GFP (Fig. 1A) , and an N-terminal ICP8 -GFP fusion protein under the control of the CMV promoter pCMV-GFP8 (Fig. 1A) or the ICP8 promoter p8-8GFP (Fig. 1B) .
Localization of the ICP8 -GFP protein in transfected cells
When expressed in the absence of other viral proteins in transfected Vero cells, the ICP8 -GFP fusion protein showed a diffuse distribution within the nucleus (Fig. 2A) . The ICP8 -GFP fusion protein localized to viral replication compartments after infection with the replication-defective HD-2 ICP8 mutant virus (Fig. 2C) , which expresses the N-terminal 250 amino acid residues of ICP8 fused in-frame to lacZ. When the specific viral DNA synthesis inhibitor PAA was present during HD-2 infection, the ICP8 -GFP fusion protein localized to punctate prereplicative sites (Fig.  2E) . Similar results were observed with wild-type KOS 1.1 infection of transfected Vero cells (data not shown). The addition of GFP to the C terminus of ICP8 did not alter its localization to prereplicative sites or replication compartments in transfected Vero cells infected with HSV. Therefore, the ICP8 -GFP fusion protein behaved as described previously for wild-type ICP8 under similar conditions. The addition of GFP to the N terminus of ICP8 resulted in a protein that did not localize to replication compartments (data not shown). The N-terminal ICP8 -GFP fusion protein had a tendency to aggregate nonspecifically in the nuclei of transfected cells (data not shown). For these reasons, we used only the C-terminal ICP8 -GFP fusion protein for our experiments.
Complementation of the HD-2 mutant virus
We next tested the ability of the C-terminal ICP8 -GFP fusion protein to complement the HD-2 ICP8 mutant virus, which expresses the first 250 amino acid residues of ICP8 fused to lacZ. Vero cells transfected with the empty pCI vector plasmid or plasmids expressing either wild-type ICP8 or the ICP8 -GFP fusion proteins were infected with HD-2 virus. At 24 h postinfection, progeny virus was harvested, and the viral yield was determined on an ICP8-complementing cell line. The ICP8 -GFP fusion protein could complement the growth of HD-2 in Vero cells by 50-fold over the negative control, but this was 40-fold less than the level observed with the wild-type ICP8 protein (Table 1) . These results suggested that the addition of GFP to the C terminus of ICP8 altered one or more functions of ICP8 or that the ICP8 -GFP fusion protein was not expressed to the levels required for efficient complementation of the HD-2 virus. The N-terminal fusion protein failed to complement an ICP8 mutant virus (Taylor, 2002) .
Construction of an ICP8 -GFP recombinant virus
We constructed a recombinant HSV strain expressing the ICP8 -GFP fusion protein via homologous recombination. Purified HD-2 viral DNA and linearized pICP8 -GFP plasmid DNA were co-transfected into the V827-complementing cell line. At 4 days posttransfection, the progeny virus was harvested and plated onto V827 cells. Fluorescent plaques were identified and triply purified on V827 cells. Stocks were grown on ICP8-complementing cell lines. 
Detection of the ICP8 -GFP fusion protein in infected cells
The ICP8 -GFP fusion protein was detected in [ 35 S]methionine-and cysteine-labeled infected Vero cells at 3.5, 6.5, and 9.5 h postinfection (Fig. 3A , lanes 3, 5, and 7). While the ICP8 -GFP was expressed with kinetics similar to those of wild-type ICP8, it was expressed to lower levels. This may have been the result of lower levels of synthesis or due to a less stable protein as a result of the addition of GFP. When the fusion protein was detected by Western blot of infected Vero cell lysates with the 3-83 anti-ICP8 polyclonal antibody, it migrated near the approximate predicted molecular size of 157 kDa (Fig. 3B, lane 2) . The levels of ICP8 -GFP expressed in ICP8-complementing cells were similar to those observed in Vero cells, suggesting that the presence of wild-type ICP8 does not stabilize or otherwise increase the expression of the ICP8 -GFP fusion protein (data not shown).
Growth properties of the ICP8 -GFP recombinant virus
To determine if there was a growth defect associated with the addition of GFP to the C terminus of ICP8, we examined the kinetics of ICP8 -GFP viral growth in both ICP8-complementing V529 cells and noncomplementing Vero cells (Fig. 4) . Monolayers of cells infected at a m.o.i. of 3 were harvested at various times postinfection. The viral yield was determined on the ICP8-complementing cell line V529, and the ICP8 -GFP recombinant virus replicated on Vero cells, but the yield was increased by 150-fold on the V529-complementing cell line (Fig. 4) . The growth difference of the ICP8 -GFP recombinant virus may be due to the lower levels of ICP8 -GFP produced during infection compared with wild-type ICP8 (Fig. 3A) . It was possible that the majority of Vero cells infected with the ICP8 -GFP recombinant virus did not produce progeny virus and that only a small percentage of infected cells produced progeny, thus giving rise to a much lower yield. If only a few Vero cells were producing the bulk of the progeny virus, it would be expected that only those few Vero cells would contain replication compartments. However, the number of Vero cells containing replication compartments was not dramat- ically different from the number of V529 cells containing replication compartments (Table 2 ), but the replication compartments were smaller and in greater number in Vero cells. Taken together, these results suggested that the majority of Vero cells are replicating viral DNA and producing progeny virions, but possibly to a lower extent than in the complementing cell line. Large stocks of the ICP8 -GFP recombinant virus at titers greater than 10 8 PFU/ml were grown on an ICP8-complementing cell lines. Thus the addition of GFP to the C terminus of ICP8 did affect some function(s) required for viral replication. The presence of GFP at the C terminus may be acting in a steric manner by partially blocking an interaction required for viral replication. However, the phenotype defect of ICP8 -GFP could be complemented by wild-type ICP8.
Viral DNA synthesis by the ICP8 -GFP virus
ICP8 is required for viral DNA synthesis, so the growth defect observed in Vero cells may be due in part to decreased levels of DNA synthesis in Vero cells. We infected Vero cells with either wild-type virus or the ICP8 -GFP recombinant virus in the presence and absence of the specific viral DNA synthesis inhibitor PAA. At 16 h postinfection, the cells were harvested, and the total cellular DNA was isolated. We blotted the DNA in fivefold dilutions to a membrane and probed with an HSV-specific 32 P-labeled plasmid to quantify the relative amounts of viral DNA by PhosphoImager analysis. The values were corrected for the amount of input viral DNA, as measured by the signal from the PAA-infection samples. The amount of viral DNA at 16 h postinfection in Vero cells infected with the ICP8 -GFP virus was 3% of the level of DNA synthesized in wild-type virus-infected Vero cells (Fig. 5) , as measured by PhosphoImager analysis. Thus, a defect in viral DNA synthesis was at least partially responsible for the growth differences observed in Vero and ICP8-complementing cells.
U L 9 binding assay
To determine if the decrease in viral replication was due to the GFP moiety blocking an important protein interaction with ICP8, we tested the ability of the ICP8 -GFP fusion protein to bind to a Staphylococcus aureus protein A-U L 9 fusion protein that had previously been used to map the U L 9 sites required for ICP8 binding (Arbuckle and Stow, 1993; Boehmer et al., 1994) . As a negative control, we used a mutant protein A-U L 9 fusion protein, D27, which was incapable of binding to ICP8 (Boehmer et al., 1994) .
Approximately 90% of the wild-type ICP8 bound to the protein A-U L 9 fusion protein (Fig. 6 , lane 6), as compared with 10% of the ICP8 -GFP fusion protein (Fig. 6, lane 3) , as measured by densitometry. Neither the wild-type ICP8 nor the ICP8 -GFP protein was retained by the mutant D27 protein A-U L 9 fusion protein (data not shown). This indicated that the ICP8 -GFP fusion protein was defective for binding to U L 9, possibly because the binding site(s) may be occluded by the GFP moiety.
Characterization of intranuclear structures containing ICP8 -GFP
We first compared the distribution of ICP8 and ICP8 -GFP in Vero cells and ICP8-complementing V529 cells a The numbers of replication compartments were determined at 7.5 h postinfection with the recombinant ICP8 -GFP virus. Cells contained a range of compartments with 1 or 2 large compartments to 5 or more small compartments.
b Fifty-seven V827 cells were counted; 54 Vero cells were counted. Total DNA was isolated, vacuum-blotted to a filter in five-fold dilutions, and probed with an HSV-1-specific 32 P-labeled probe. Fig. 6 . Binding of ICP8 or ICP8 -GFP to a protein A-U L 9 fusion protein preabsorbed to IgG Sepharose. Protein extracts obtained from transfected 293 cells were mixed batchwise with a protein A-U L 9 fusion protein immobilized to IgG Sepharose. After the unbound fraction (FT) was collected, the IgG Sepharose was washed with 100 mM NaCl low-salt buffer (LS) and then 1 M NaCl high-salt buffer (HS). A portion of each fraction (1/10 volume) was separated by SDS-PAGE, blotted to membrane, and probed with the 3-83 polyclonal anti-ICP8 antibody.
using standard immunofluorescence techniques. ICP8 and ICP8 -GFP were found in similar globular structures in Vero cells (Figs. 7A and C, respectively) and in V529 cells (Figs. 7B and E, respectively) , suggesting that the structures formed by ICP8 -GFP in Vero and V529 cells were replication compartments.
Wild-type ICP8 reacts with the 39S conformation-specific monoclonal antibody only when it is localized to prereplicative sites or replication compartments (S.L. Uprichard, D.M. Knipe, submitted for publication). As the addition of GFP may have altered the conformation of ICP8, we used immunofluorescence to determine if the ICP8 -GFP fusion protein contained within replication compartments was detected with the 39S monoclonal antibody. We infected Vero cells with recombinant ICP8 -GFP virus, and at 5.5 h postinfection we processed the cells for immunofluorescence. ICP8 -GFP was detected by the 39S monoclonal antibody (Fig. 8B) , suggesting that the addition of GFP did not significantly alter the conformation of ICP8 and that the ICP8 -GFP fusion protein adopted a conformation similar to that of wild-type ICP8 within replication compartments.
To further demonstrate that the ICP8 -GFP-containing structures in the nucleus were similar to wild-type replication compartments and not nonspecific aggregates of the ICP8 -GFP fusion protein, we determined if other viral replication compartment proteins were present in infected Vero cells within the ICP8 -GFP-containing structures via indirect immunofluorescence. Both the major viral transactivator ICP4 (Fig. 8D ) and the polymerase processivity factor U L 42 (Fig. 8G) , previously shown to localize to replication compartments (de Bruyn Kops et al., 1998; Knipe et al., 1987; Liptak et al., 1996; Randall and Dinwoodie, 1986) , co-localized with the ICP8 -GFP fusion protein in replication compartments within the nucleus (Figs. 8F and I, respectively). Therefore, the ICP8 -GFP-containing structures were similar in protein composition to wildtype replication compartments and not simply aggregates of the ICP8 -GFP fusion protein; thus, ICP8 -GFP localized to normal replication structures in infected cells. These conditions provided a system to study ICP8 localization in living cells.
ICP8-GFP distribution in fixed cells
We next observed replication compartment formation in Vero cells and the ICP8-complementing cell line V827 at 4 and 6.5 h postinfection with the recombinant ICP8 -GFP virus. At 4 h postinfection, the majority of ICP8 -GFP was distributed diffusely within the nucleus, but several small structures similar to prereplicative sites were observed (Fig.  9A) . These small sites were composed of only one or two foci that contained the ICP8 -GFP fusion protein (Fig. 9G) . In the V827-complementing cells, the infection in many of the cells had progressed beyond the individual foci or doublets and these cells contained what appeared to be small compartments each consisting of several ICP8 -GFP foci (Fig. 9B) .
At 6.5 h postinfection, larger compartments were observed in both the Vero and the complementing V827 cells (Figs. 9C and D, respectively) . The smaller compartment size observed in the Vero cells compared with the V827 cells may be due in part to the lower level of ICP8 -GFP viral DNA synthesis in Vero cells or the lower levels of ICP8 -GFP fusion protein compared with wild-type ICP8 protein. In both cell types, when PAA was added, the expected punctate prereplicative sites were observed (Figs.  9E and F) . Because the replication compartments were larger in the ICP8-complementing cell line, we used these cells in all future experiments for visualizing replication compartment formation.
Time-lapse microscopy of replication compartment formation
To follow the maturation of replication compartments in cultured cells, we infected V827 cells with the ICP8 -GFP recombinant virus and acquired images at various intervals of time. Intranuclear movement was observed on two scales. On a small scale, the individual foci containing ICP8 -GFP that made up the replication compartments were not static, but appeared to rotate in place or move relatively short distances (less than the diameter of the foci) within a time frame of seconds (not shown). In addition, on a larger scale, small replication compartments moved through the nucleus to merge or fuse with neighboring structures. This movement took place over a time frame of minutes and greater intranuclear distances (over 1 m). At 4.5 h postinfection, the majority of ICP8 -GFP was distributed diffusely in the nucleus, with only a few punctate prereplicative sites (Fig.  10A ) or small replication compartments (Fig. 10B) observed. The three arrows in Fig. 10A at 4 h 12 min postinfection indicate three structures that coalesced to form the larger compartment indicated with the arrow by 5 h 30 min postinfection. In other cells, small replication compartments increased in size until merging with neighboring structures (Fig. 10B) . Large replication compartments merged with neighboring structures to eventually occupy the entire nucleus (Fig. 11) . The movie versions of the data may be seen on our web site at http://knipelab.med.harvard.edu.
Discussion

ICP8-GFP fusion protein
In this study, we describe the construction and use of a recombinant HSV-1 strain that expresses an ICP8 -GFP fusion protein to examine the dynamic intranuclear movement of ICP8 into prereplicative sites and replication com- Fig. 7 . Comparison of ICP8 and ICP8 -GFP distribution patterns. Vero or V529 cells were infected with either wt or the ICP8 -GFP recombinant virus. At 5.5 h postinfection, the cells were processed for immunofluorescence. The 39S MAb was used to detect both ICP8 and ICP8 -GFP with a rhodamineconjugated secondary antibody. The ICP8 -GFP fusion protein was also detected by GFP fluorescence. (A) Distribution of ICP8 in a Vero cell; (B) distribution of ICP8 in a V529 cell; (C) distribution of ICP8 -GFP in a Vero cell as detected by the 39S MAb; (D) GFP fluorescence of (C), (E) distribution of ICP8 -GFP in a V529 cell as detected by the 39S MAb, (F) GFP fluorescence of (E). partments. The addition of GFP to the carboxy terminus of ICP8 resulted in a fusion protein that was partially functional; however, the defect could be complemented by the presence of wild-type ICP8 supplied in trans by infection with wild-type HSV or by an ICP8-expressing cell line. It is possible that the GFP portion blocks or restricts a region of ICP8 that is required for the interaction with viral or cellular proteins or that lower levels of ICP8 -GFP made during infection may contribute to the observed growth defect. If this is the case, then the decreased level of ICP8 -GFP may not be sufficient to perform all the required activities of ICP8 during infection. The presence of wild-type ICP8 in complementing cells may stimulate viral DNA synthesis or act in concert with the ICP8 -GFP fusion protein to recruit viral or cellular proteins required for replication or it may simply increase the overall amount of ICP8 expressed during the infection. The growth defect in Vero cells could be accounted for in part by a 30-fold decrease in viral DNA synthesis, which was probably due in part to the greater than 10-fold decrease in the ability of the ICP8 -GFP fusion protein to bind the U L 9 origin-binding protein. U L 9 is required for origin-dependent viral DNA synthesis (Challberg, 1986) , and it has been shown previously that the ICP8 -U L 9 interaction is required for efficient origin-dependent DNA synthesis (Boehmer et al., 1994) . In an insect cell-based, HSV-1 origin-dependent DNA replication assay, the U L 9 mutant UL9DM27, which no longer interacts with ICP8 but retains origin binding and helicase activities, displayed only 5% of the levels of origin-dependent DNA synthesis compared with wild-type U L 9 controls (Boehmer et al., 1994) . This level of DNA synthesis is comparable to the amount that we observed after infection of Vero cells with the ICP8 -GFP virus, indicating that the decreased binding of U L 9 by ICP8 -GFP may account for the lower levels of DNA replication observed in Vero cells. It is possible that the GFP portion blocks or restricts a region of ICP8 that is required for the interaction with U L 9. In ICP8-complementing cells infected with the recombinant ICP8 -GFP virus, the wild-type ICP8 may interact with U L 9, thus initiating viral DNA synthesis. This does not imply that the only interaction disrupted by the addition of GFP is with U L 9; moreover, the GFP moiety may block interactions in a larger replication complex that includes ICP8 or other interactions that have not yet been described. Despite the lowered level of viral DNA replication detected in infected Vero cells, prereplicative sites and replication compartments were observed, suggesting that the decreased level of DNA synthesis was sufficient to promote replication compartment formation. This suggests that the ICP8 -U L 9 interaction may not be directly required for ICP8 intranuclear targeting and for the formation of replication compartments. However, it is possible that the weaker binding of ICP8 -GFP to U L 9 may be sufficient for intranuclear localization to prereplicative sites. Previous studies have shown that in transfected Vero cells, co-expression of the three subunits of the helicase-primase complex with wild-type ICP8 was sufficient to localize ICP8 to prereplicative sites (Liptak et al., 1996) , suggesting, that in certain circumstances, U L 9 is not absolutely required for the intranuclear localization of ICP8.
The intranuclear structures containing the ICP8 -GFP fusion protein had properties similar to those previously reported for wild-type ICP8-containing replication compartments. For example, the ICP8 -GFP fusion protein co-localized with the ICP4 and U L 42 proteins, both of which localize to replication compartments. The ICP8 -GFP protein intranuclear distribution was also similar to that observed for wild-type ICP8, which consisted of punctate foci within the boundaries of the replication compartment. These data supported the use of the ICP8 -GFP protein as a model for intranuclear targeting of ICP8. 
Intranuclear movement of viral replication structures
We show here that the HSV prereplicative sites and replication compartments initiate at a few distinct structures and then at least some traverse through the intranuclear environment to fuse with one another. Early during infection, the ICP8 -GFP fusion protein localized to several small structures within the nucleus. It is unknown if the ICP8 -GFP fusion protein is targeting to a preexisting cellular structure that is adjacent to ND10 or if viral proteins accumulate at a new intranuclear structure required for viral DNA replication or gene expression. It has recently been reported that cellular sites of DNA synthesis initiate at a few sites within the nucleus (Kennedy et al., 2000) . It is possible that viral proteins, including ICP8 -GFP, localize to a subpopulation of cellular replication sites that form adjacent to ND10. Further studies are required to determine if ICP8 or other viral proteins co-localize with mammalian originassociated proteins, such as those in the ORC or MCM families. If this is true, then, it is possible that the virus is usurping preformed cellular DNA replication complexes to aid in its own DNA replication.
The coalescence of smaller, distant sites or the merging of neighboring replication compartments formed larger compartments that eventually filled the nucleus. We observed movement on two scales. The first was a rapid, small-scale local movement of individual ICP8 -GFP foci within replication compartments that occurred over short distances. The second type involved movement over greater intranuclear distances but on a slower time frame on the order of minutes. To summarize, once prereplicative sites or small compartments formed, large replication compartments formed by two mechanisms: (1) distant, small structures moved to coalesce into larger compartments (Fig.  12A) , and (2) the compartments grew by accretion while maintaining the same relative position within the nucleus and larger compartments formed when the boundaries of adjacent compartments merged (Fig. 12B) .
Multiple mechanisms may be responsible for replication compartment movement and coalescence. To address this, we must first consider the types of intranuclear movements observed normally in cells. Many studies suggest that chromatin movement is restrained during interphase in the mammalian nucleus, with movements restricted to Ͻ0.3-0.5 m, which is the result of Brownian motion or diffusion (Abney, 1997; Manders et al., 1999; Marshall et al., 1997; Shelby et al., 1996; Zink et al., 1998) . These mechanisms may account for the rapid, small-scale movements of the ICP8 -GFP foci, but possibly not for the large-scale movements of replication compartments. Despite the evidence of a relatively immobile mammalian cell nucleus, at least one report has shown evidence for cell cycle-regulated intranuclear chromatin movement (Tumbar and Belmont, 2001 ). This was demonstrated when a region of transcriptionally silent chromatin located normally at the nuclear periphery was permanently redistributed to the nuclear interior on insertion of a transcriptionally active locus (Tumbar and Belmont, 2001) . This large-scale movement took place on a time scale of minutes, but only during G 1 or S phase. More evidence exists for cell cycle-and developmentally regulated intranuclear movement in other organisms such as Drosophila (Gunawardena and Rykowski, 2000; Vazquez et al., 2001) or budding yeast (Heun et al., 2001 ), but these organisms may have a functionally different nuclear architecture compared with mammalian cells due to increased heterochromatin amounts in mammalian cells, which may limit intranuclear movements. The mechanisms required for these examples of intranuclear movements are unknown, and it remains to be determined whether active or passive forces are responsible.
It is intriguing to suggest that an active mechanism is responsible for the movements of prereplicative sites and replication compartments. It is possible that the virus may assemble an intranuclear molecular motor that can propel compartments through the interchromosomal spaces. Motors consisting of actin and myosin are well documented in the cytoplasm, but their presence or action in the nucleus has not been conclusively demonstrated. Recently, it was proposed that actin filaments play a role in the activity of a transcriptional complex (Zhao, 1998) , suggesting that an actin-dependent activity is required in the nucleus. Others have demonstrated that nuclear myosin 1 interacted and co-localized with RNA polymerase II (Nowak et al., 1997; Pestic-Dragovich et al., 2000) , again suggesting that molecular motors exist and have a functional role in the nucleus. Future work is required to determine if molecular motor proteins, such as actin and myosin, are required for viral replication compartment coalescence. However replication compartment coalescence is directed, it is clear that this has a profound effect on the preexisting nuclear architecture. It has been shown recently that herpesviruses may have evolved mechanisms for disrupting the nuclear lamina (Muranyi et al., 2002; Scott and O'Hare, 2001 ). The disruption of nuclear laminins, which are an integral part of the nuclear framework, may lead to a higher nuclear plasticity, thus allowing for the movement of viral replication structures. In HSV-infected cells, other compartments within the nucleus may be altered and the chromatin is marginalized to the nuclear periphery (Darlington and James, 1966; Monier et al., 2000; Schwartz and Roizman, 1969; Sirtori and BosisioBesteti, 1967) . Channels of nucleoplasm that normally run throughout the interchromosomal space to the nuclear pores may be blocked or disrupted by the growth of replication compartments, thus possibly inhibiting or slowing normal cellular functions such as mRNA trafficking out to the cytoplasm. This may be another general mechanism for how HSV alters cellular functions to promote its own replicative success.
Materials and methods
Cells and viruses
African green monkey kidney (Vero) and human 293 cells were grown and maintained in Dulbecco's modified Eagle's medium (Mediatech, Inc.) with 5% fetal bovine serum ϩ 5% fetal calf serum, glutamine, streptomycin, and penicillin (DMEM ϩ 10% FCS). The ICP8-complementing cell lines S2 (Gao and Knipe, 1989) , V827 (Da Costa et al., 2000) , and V529 (Da Costa et al., 2000) , which express ICP8, ICP8 and ICP27, and ICP8 and U L 5, respectively, were grown and maintained in DMEM ϩ 10% FCS ϩ G418 (400 g/ml).
The herpes simplex 1 KOS 1.1 wild-type strain, originally obtained from M. Levine, was propagated and assayed on Vero cells. The HD-2 mutant virus (Gao and Knipe, 1989 ) is a replication-defective HSV-1 strain that expresses the first 250 amino acid residues of ICP8 fused to ␤-galactosidase. The ICP8 -GFP recombinant virus and the HD-2 mutant ICP8 virus were propagated on either S2 or V827 cells.
Plasmids
To construct pICP8 -GFP, sequences encoding ICP8 and green fluorescent protein (GFP) were first cloned into the pCI (Promega)-derived vector pCI⌬AflII (Murphy et al., 2000) as follows. A 732-bp NotI fragment containing the GFP open reading frame (ORF) from pGreenLantern (Gibco-BRL) was cloned into the NotI site of pCI⌬AflII to generate pCI⌬A-GFP. A 3.8-kb EcoRI/AvrII fragment containing the entire ICP8 ORF from pSV8.2 (Gao and Knipe, 1993) was cloned into the EcoRI and XbaI sites of pCI⌬A-GFP. The fusion protein ORF was generated by mutating the ICP8 stop codon via polymerase chain reaction (PCR)-mediated site-directed mutagenesis with Pfu DNA polymerase (Stratagene) (1 cycle 95°C 2 min; 12 cycles 95°C 30 s, 55°C 1 min, 68°C 18 min). The two primers used for changing the stop codon to an arginine residue were 5Ј-CAACCCCTCTCAGCATATCCAACG-3Ј (antisense) and 5Ј-CGTTGGATATGCTGAGAGGGGTTG-3Ј (sense) (Life Technologies). The altered nucleotide is in boldface. After PCR amplification, the reaction was digested with DpnI, and 1 l of the reaction was used to transform bacteria. The resulting vector was designated pCMV-8GFP.
The pCMV-8.3 plasmid was generated by removing the 3.8-kb EcoRI/AvrII fragment containing the ICP8 sequence from the pSV8.3 plasmid and subcloning it into the EcoRI and XbaI sites of pCI⌬AfIII.
Isolation of a recombinant HSV-1 expressing the ICP8 -GFP fusion protein
The sequence encoding the C-terminal ICP8 -GFP fusion protein from pCMV-8GFP was cloned into a vector containing U L 29 flanking sequences as follows. The EcoRI site 172 nucleotides upstream from the ICP8 start codon and the HpaI site 147 nucleotides downstream of the GFP stop codon in pCMV-8GFP were filled in and converted to BglII restriction sites by the insertion of a 12-bp BglII oligonucleotide linker (5Ј-GGAAGATCTTCC-3Ј) (New England Biolabs). The resulting 4.7-kb BglII fragment was cloned into the BglII site of pICP8PA (M. Chen, D.M. Knipe, unpublished results), a plasmid that contains the ICP8 promoter, poly(A), and additional downstream sequence, to make the plasmid p8-8GFP. To generate the ICP8 -GFP recombinant virus via homologous recombination, linearized p8-8GFP and HD-2 viral DNA (Gao and Knipe, 1989) were co-transfected via the calcium phosphate method into the V827-complementing cell line. HD-2 is a replicationdefective virus that expresses a truncated ICP8 fused to the ␤-gal. Linear p8-8GFP was transfected with various molar ratios of HD-2 viral DNA to plasmid DNA (1:10, 1:15, 1:20) and brought to a total of 16 g DNA with salmon sperm DNA. An equal volume of 2ϫ HEPES-buffered saline, pH 7.05 (270 mM NaCl, 10 mM KCl, 1.4 mM Na 2 HPO 4 , 2% dextrose, 42 mM HEPES) was added to the DNA. The volume was brought up to 600 l with 1ϫ Hepes-buffered saline, and then 40 l of 2.0 M CaCl 2 was added dropwise. The tubes were mixed gently and incubated at room temperature for 15 min. The suspension was then added to flasks of subconfluent V827 cells and incubated at room temperature for 30 min, after which 5 ml of DMEMϩ 10% FBS was added, and the flasks were placed at 37°C. On the following day, the cells were washed twice and overlain with fresh medium. Four days later, the cells were harvested by adding 2.5 ml sterile milk and freeze-thawing twice. The lysate was sonicated three times on ice for 30 s on/ 30 s off. The lysate was then serially diluted and plated on V827 cells. An inverted, fluorescent Nikon microscope equipped with a FITC filter set was used to screen for fluorescent plaques.
Complementation assay
Vero cells in six-well plates were transfected in duplicate using the Lipofectamine reagent (Gibco-BRL) with 1 g of pCMV-8.3 or pCMV-8GFP and 3 g carrier DNA, or 4 g carrier DNA as a negative control. At 24 h posttransfection, the cells were infected at a m.o.i. of 5 with HD-2. At one hour postinfection, the cells were washed (40 mM sodium citrate, 135 mM NaCl, 10 mM KCl, pH 3.0) twice for 30 s to inactivate excess extracellular virus. The cells were harvested 24 h later by freeze-thawing twice and sonicating three times on ice for 30 s. The yield was determined by titration on the S2-complementing cell line.
Viral yield assay
Vero or V529 cells in T25 flasks were infected at a m.o.i. of 3 with either wild-type KOS 1.1 or the recombinant ICP8 -GFP virus. One hour after infection the cells were washed (40 mM sodium citrate, 135 mM NaCl, 10 mM KCl, pH 3.0) to inactivate extracellular virus. At 2, 12, or 24 h postinfection, the cells were harvested by freeze-thawing and sonicating three times for 30 s on ice. The yield was determined by titration on V529 cells.
Viral DNA synthesis assays
Vero cell monolayers were infected with either KOS1.1 or the ICP8 -GFP virus at a m.o.i. of 10 in the presence or absence of a specific viral DNA inhibitor, phosphonoacetic acid (PAA), at a concentration of 400 g/ml. At 16 h postinfection, total DNA was obtained by disrupting the cells in 3 ml of lysis buffer (10 mM Tris-Cl, pH 8.0, 10 mM EDTA, pH 8.0, 2% SDS, 100 g/ml proteinase K) and incubating overnight at 37°C. After the addition of 0.3 ml of 3 M sodium acetate (pH 5.2), lysates were extracted once with phenol:chloroform and then once with chloroform. After precipitation with 2 vol of 70% ethanol and resuspension in 700 of l TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA), the lysate was incubated with RNase A (25 g/ml) for 30 min at 37°C. Seventy microliters of 3 M sodium acetate (pH 5.2) was added, and the samples were once again extracted with phenol:chloroform and then once with chloroform. The DNA was precipitated on ice for 1 h by the addition of an equal volume of 1.6 M NaCl-13% PEG. The DNA was then resuspended in TE buffer and quantitated. Equivalent amounts of DNA were applied to a nitrocellulose filter in fivefold dilutions (2000 -16 ng in 12ϫ SSC) via a dot-blotter apparatus. The filter was then probed with the HSV-1-specific 32 P-labeled plasmid pSV8.3. Exposure and quantification of the filter were with a Bio-Rad GS-525 Molecular Imager and Multi-Analyst software.
Preparation of protein extracts
Protein extracts were obtained from two 150-cm 2 culture flasks of 293 cells transfected with either pSV8.3 or pCMV-8GFP DNA with the SuperFect reagent (Qiagen) as per the manufacturer's instructions. At 48 h posttransfection, the cells were washed twice with phosphate-buffered saline, pelleted, and resuspended in 2 ml of high-salt buffer (1.2 M NaCl, 20 mM HEPES-NaOH, pH 7.5, 10% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, one Complete-Mini protease inhibitor cocktail tablet (Roche) per 7 ml buffer). The lysates were sonicated on ice three times for 30 s and then clarified by centrifugation at 4°C in an Eppendorf microfuge. The lysates were dialyzed overnight against lowsalt buffer (100 mM NaCl, 20 mM HEPES-NaOH, pH 7.5, 10% (v/v) glycerol, 1 mM DTT, 0.1 mM EDTA), and then cleared by centrifugation at 4°C for 30 min in an Eppendorf microfuge. After the addition of 1 M MgCl 2 to 20 mM and 200 units of DNase I, the lysates were incubated at 4°C for 2 h and then stored at Ϫ80°C.
U L 9 binding assay
Five hundred-milliliter cultures of DH5 Escherichia coli containing either the pB1 or pD27 plasmid were grown in Luria broth overnight at 37°C. The pelleted cells were washed three times with 100 ml TE (10 mM Tris-HCl, pH 7.6, 1 mM EDTA). After resuspension in 10 ml of lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20, 1 mM EDTA, one Complete-Mini protease inhibitor cocktail tablet per 10 ml buffer), lysozyme was added to 200 g/ml, and the cells were incubated at room temperature for 20 min. The cells were sonicated on ice, and the lysates were clarified by centrifugation at 4°C in a Sorvall centrifuge at 15,000 rpm for 1 h. The lysates were incubated overnight at 4°C after the addition of 1 M MgCl 2 to 20 mM and 400 units of DNase I. The lysates were aliquoted and stored at Ϫ80°C.
One milliliter of B1 or D27 lysate was added to 0.5 ml of IgG Sepharose Fast Flow 6, equilibrated as per the manufacturer's directions (Pharmacia Biotech), batchwise in microfuge tubes. The slurry was incubated at 4°C for 30 min with gentle agitation. The IgG Sepharose slurry was washed three times with TST buffer (50 mM Tris-Cl, pH 7.6, 150 mM NaCl, 0.05% Tween 20), and then twice with low-salt buffer (100 mM NaCl, 20 mM HEPES-NaOH, pH 7.5, 10% (v/v) glycerol, 1 mM DTT, 0.1 mM EDTA). After 0.5 ml of either wild-type ICP8 or ICP8 -GFP extract was added to the protein A-U L 9/IgG Sepharose preparations, the slurry was incubated for 1 h at 4°C with gentle agitation. The slurry was centrifuged at 4°C in an Eppendorf microfuge for 1 min. The supernatant was removed and kept as the flowthrough fraction. The slurry was subsequently washed twice with 0.5 ml of low-salt buffer and then 0.5 ml of high-salt elution buffer (1 M NaCl, 20 mM HEPES-NaOH, pH 7.5, 10% (v/v) glycerol, 1 mM DTT, 0.1 mM EDTA). The two 0.5-ml wash fractions were combined for a final volume of 1 ml. A portion of each fraction (1/10 vol) was separated by SDS-PAGE, transferred to a PVDF membrane (Bio-Rad), and probed with the ICP8 3-83 polyclonal antibody. Input and recovery of protein was monitored by loading decreasing twofold dilutions of total lysate equivalent to 1/10th, 1/20th, and 1/40th of the lysate on a gel that was prepared in parallel. The amount bound was determined as the percentage of total protein in the high-salt fraction as measured by densitometry of the film.
Visualization of ICP8-GFP
Vero or V529 cells were grown on 22 ϫ 22-mm coverslips in six-well trays. For short-term live cell analysis, the coverslip was removed at the indicated time postinfection, washed briefly in PBS, and then placed onto a glass slide for observation. For fixed cell analysis, the coverslip was washed in PBS, fixed for 5 min in 3.7% formaldehyde in PBS, washed twice in PBS and once in distilled water, and then mounted onto glass slides with gelatin.
Cells were viewed with an Axioplan 2 (Zeiss) microscope equipped with an Orca cooled CCD camera (Hamamatsu Photonics). A Zeiss 40ϫ or 63ϫ plan Apochromat objective was used. Images were collected with the OpenLab software package (Improvision). Figures were prepared with Canvas 5.0 (Deneba).
Indirect immunofluorescence
For indirect immunofluorescence of cultured cells, Vero cells were plated on 18-mm coverslips in a 24-well tray. At 5.5 h postinfection with the ICP8 -GFP virus, the cells were washed briefly in PBS and then fixed for 5 min in 3.7% formaldehyde in PBS. After being washed with PBS for 5 min, the cells were subsequently permeabilized with cold acetone for 2 min. The cells were then rinsed in distilled water and washed for 5 min in PBS. Primary antibody was then applied at a 1:50 dilution of one of the following: the 58S anti-ICP4 monoclonal antibody, the 39S anti-ICP8 monoclonal antibody, or the 5H11D6 anti-U L 42 monoclonal antibody. After being washed three times for 5 min in PBS, a 1:100 dilution of a rhodamine-conjugated goat antimouse antibody was used as a secondary antibody for detection. After a final wash in PBS, the coverslips were mounted onto glass slides with gelatin. The same microscope setup used for observing ICP8 -GFP was used for indirect immunofluorescence.
Analysis of viral proteins
Vero cells in 25-cm 2 culture flasks were mock-infected or infected at a m.o.i. of 10 with wild-type KOS 1.1, the recombinant ICP8 -GFP virus, or the replication-defective virus HD-2. At the indicated times postinfection, the cells were incubated for 30 min at 37°C in labeling medium (Eagle's minimum essential medium, without methionine or cysteine (Sigma), supplemented with 1% dialyzed fetal bovine serum and 100 Ci/ml EXPRE 35 S 35 S labeling mix (NEN)). The cells were harvested by the addition of 1 ml of SDS sample buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 200 mM DTT, 0.2% bromphenol blue). The proteins were separated on a 9.25% gel by SDS-PAGE. The gel was dried and exposed to BioMax MR film (Kodak).
For immunodetection of the ICP8 protein by Western blot, the 3-83 polyclonal antibody was used at a dilution of 1:1000 in TBST (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Tween 20). The membrane was blocked with TBST plus 5% milk for 30 min at room temperature before the addition of 3-83 antiserum. The membrane was washed three times for 15 min with TBST at room temperature after primary and secondary antibody incubations. An HRP-conjugated goat anti-rabbit secondary antibody (Santa Cruz Biotechnology) was used at a dilution of 1:5000 in TBST. Enhanced chemiluminescence reagents were used as directed by the manufacturer (Amersham Pharmacia Biotech).
Time-lapse video microscopy
S2 cells for time-lapse analysis were grown on 18-mm glass coverslips in six-well plates. A DeltaVision microscope system (Applied Precision Instruments) assembled around an Axiovert microscope (Zeiss) and a PXL CCD camera (Photometrics Ltd.) was used to view the cells. A Zeiss 63X plan Apochromat objective was used. The temperature was held constant at 37°C with an objective warmer (Bioptechs, Inc.). Cells were maintained in CO 2 independent medium (Gibco-BRL) plus 1% heat-inactivated fetal bovine serum for the duration of the time-lapse procedure.
